fbpx

MTL Cannabis Corp. Reports Record First Quarter Results with $25.8 Million of Revenue

MTL Cannabis Corp. (CSE: MTLC) is pleased to report it has filed the financial statements as at and for the three-month period ending June 30, 2024, and 2023. Complete details may be found at www.sedarplus.ca.

First Quarter 2025 Consolidated Financial Highlights for MTL Cannabis:

Income Statement:

  • Revenue of $25,842,264, an improvement of $8,978,969, or 53%, compared to $16,863,295 in the same quarter of last year.
  • Net Revenue of $20,721,232, an improvement of $7,957,445, compared to $12,763,787 in the same quarter of last year.
  • Gross margin before fair value adjustments of 54%, an increase of 16%, compared to 38% in the same quarter of last year.
  • Operating Income of $4,963,969, an improvement of $4,364,370, compared to $599,599 in the same quarter of last year.
  • Net Income and Comprehensive Income of $2,206,313, an improvement of $2,393,161, compared to a loss of ($186,848) in the same quarter of last year.

Statement of Cash Flows:

  • Net cash inflows from operating activities of $5,602,954, compared to $2,140,029 in the same period of last year.
  • Net cash used in investing activities of ($1,924,128), compared to ($318,847) in the same period of last year.
  • Net cash used in financing activities of ($2,774,581), compared to ($1,291,189) in the same period of last year.
  • Overall net cash increased to $2,256,380, an improvement of $904,245, from $1,352,135 at the beginning of the period.

Additionally, the company was able to demonstrate retained earnings of $1,545,148, compared to an accumulated deficit of ($614,165) in the same period of last year.

Management Commentary:

“We are incredibly proud of our team and the progress we have made as a company,” said Michael Perron, CEO of MTL.  “We look forward to continuing to deliver best in class products and services to our incredible customers and patients.”


You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More